These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 19342848

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC, Rabinstein AA.
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [Abstract] [Full Text] [Related]

  • 5. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry.
    Shobha N, Buchan AM, Hill MD, Canadian Alteplase for Stroke Effectiveness Study (CASES).
    Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345
    [Abstract] [Full Text] [Related]

  • 6. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
    Sobesky J, Frackowiak M, Zaro Weber O, Hahn M, Möller-Hartmann W, Rudolf J, Neveling M, Grond M, Schmulling S, Jacobs A, Heiss WD.
    Cerebrovasc Dis; 2007; 24(1):56-65. PubMed ID: 17519545
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA, Starr JA.
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
    Sølling C, Hjort N, Ashkanian M, Østergaard L, Andersen G.
    Cerebrovasc Dis; 2009 Mar; 27(3):223-9. PubMed ID: 19176954
    [Abstract] [Full Text] [Related]

  • 11. The Belgian experience with intravenous thrombolysis for acute ischemic stroke.
    Vanacker P, Thijs V, Peeters A, Bruneel B, Laloux P, Druwé P, De Deyn P, Ahmed N, Wahlgren N, Vanhooren G, Belgian SITS-collaboration group.
    Acta Neurol Belg; 2010 Jun; 110(2):157-62. PubMed ID: 20873445
    [Abstract] [Full Text] [Related]

  • 12. Thrombolysis for acute ischemic stroke.
    Hajjar K, Kerr DM, Lees KR.
    J Vasc Surg; 2011 Sep; 54(3):901-7. PubMed ID: 21889708
    [Abstract] [Full Text] [Related]

  • 13. [Thrombolytic therapy for acute ischemic stroke. Experience of SITS (Safe Implementation of Thrombolysis in Stroke) register].
    Rodríguez-Yáñez M, Alvarez-Sabín J, Dávalos A, Díez-Tejedor E, Castillo J.
    Neurologia; 2009 Jun; 24(5):288-91. PubMed ID: 19642029
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis.
    Strbian D, Sairanen T, Meretoja A, Pitkäniemi J, Putaala J, Salonen O, Silvennoinen H, Kaste M, Tatlisumak T, Helsinki Stroke Thrombolysis Registry Group.
    Neurology; 2011 Jul 26; 77(4):341-8. PubMed ID: 21715707
    [Abstract] [Full Text] [Related]

  • 16. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).
    Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Dávalos A, Erilä T, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Köhrmann M, Larrue V, Lees KR, Machnig T, Roine RO, Toni D, Vanhooren G, Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy Investigators.
    Stroke; 2008 Dec 26; 39(12):3316-22. PubMed ID: 18927461
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).
    Eissa A, Krass I, Bajorek BV.
    J Clin Pharm Ther; 2012 Dec 26; 37(6):620-9. PubMed ID: 22708668
    [Abstract] [Full Text] [Related]

  • 19. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T, Minematsu K.
    Brain Nerve; 2009 Sep 26; 61(9):1003-12. PubMed ID: 19803399
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.